Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

aps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

As the American Society of Hematology (ASH)’s annual conference wraps up this week, Regeneron is using it as an opportunity to tout its hematology pipeline — and early data on two blood cancer drugs.

Of the 2,000,000 or more Americans who get transfusions every year, too many die on the operating table, and some as the result of a medical mistake. Surgeons and anesthesiologists, who are cautious ...

While crossing a Philadelphia street a year ago, Amelia Hutson, 24, mother of six, was hit by a car. She suffered a broken right leg and left thigh. At Temple University Hospital she got a one-pint ...

SAN ANTONIO – Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are no longer the terminal diagnoses that ...

Please provide your email address to receive an email when new articles are posted on . Treatment of blood cancers such as non-Hodgkin lymphoma and multiple myeloma has improved dramatically over the ...

Clinical trials to explore the use of universal artificial blood are underway in Japan after initial volunteer doses began in March. The research, led by Professor Hiromi Sakai's laboratory, plans to ...

In March, people crowded around BetterWay blood testing's exhibit space in the Austin Convention Center during South by Southwest. They watched people have their blood drawn from their fingertips to ...